Literature DB >> 23571460

Comparison of characteristics of bacterial bloodstream infection between adult patients with allogeneic and autologous hematopoietic stem cell transplantation.

Junshik Hong1, Song Mi Moon, Hee Kyung Ahn, Sun Jin Sym, Yoon Soo Park, Jinny Park, Yong Kyun Cho, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee.   

Abstract

Although autologous and allogeneic hematopoietic stem cell transplantation (HSCT) are fundamentally different procedures, a tailored approach to bacterial bloodstream infection (BSI) according to the type of HSCT has not yet been suggested. We evaluated the characteristics of BSI after HSCT, with a focus on comparison of BSIs between recipients of autologous HSCT (auto-HSCT) and allogeneic HSCT (allo-HSCT). Among 134 patients (59 received allo-HSCT and 75 received auto-HSCT) who underwent HSCT, BSIs were reported earlier in patients who underwent auto-HSCT, compared with those who underwent allo-HSCT (mean 12.1 ± 3.4 days versus 32.8 ± 27.1 days, P = .006). Among patients receiving allo-HSCT, postneutrophil-engraftment bacterial BSI showed an association with grade ≥ 2 acute graft-versus-host disease (GVHD). In patients who underwent auto-HSCT, results of multivariate analysis showed that not receiving prophylactic antibiotics (P = .004) and having elevated serum C-reactive protein (P = .034) were risk factors of BSI. Elevated CRP (P = .01) and acute GVHD ≥ grade 2 (P = .002) were independent risk factors in patients who underwent allo-HSCT. Those differences originated mainly from the impact of acute GVHD-related postengraftment BSIs of patients who underwent allo-HSCT. To establish the best defense strategy against BSI, the distinctive natures of bacterial BSI after HSCT between auto-HSCT and allo-HSCT should be considered.
Copyright © 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23571460     DOI: 10.1016/j.bbmt.2013.03.019

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  11 in total

1.  Empiric antibiotic use in allogeneic hematopoietic cell transplantation: should we avoid anaerobe coverage?

Authors:  Yusuke Shono; Marcel R M van den Brink
Journal:  Blood Adv       Date:  2017-11-17

2.  Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.

Authors:  Dipenkumar Modi; Hyejeong Jang; Seongho Kim; Malini Surapaneni; Kamya Sankar; Abhinav Deol; Lois Ayash; Divaya Bhutani; Lawrence G Lum; Voravit Ratanatharathorn; Richard Manasa; Kendra Mellert; Pranatharthi Chandrasekar; Joseph P Uberti
Journal:  Support Care Cancer       Date:  2017-04-02       Impact factor: 3.603

3.  Pre-treatment blood inflammatory markers as predictors of systemic infection during induction chemotherapy: results of an exploratory study in patients with acute myeloid leukemia.

Authors:  Junshik Hong; Hyun Seon Woo; Hee Kyung Ahn; Sun Jin Sym; Jinny Park; Eun Kyung Cho; Dong Bok Shin; Jae Hoon Lee
Journal:  Support Care Cancer       Date:  2015-05-19       Impact factor: 3.603

Review 4.  The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.

Authors:  Anna Staffas; Marina Burgos da Silva; Marcel R M van den Brink
Journal:  Blood       Date:  2016-12-09       Impact factor: 22.113

5.  G-CSF-primed haplo-identical HSCT with intensive immunosuppressive and myelosuppressive treatments does not increase the risk of pre-engraftment bloodstream infection: a multicenter case-control study.

Authors:  Jinhua Ren; Qiaoxian Lin; Weimin Chen; Congmeng Lin; Yuxin Zhang; Cunrong Chen; Shaozhen Chen; Xiaohong Yuan; Ping Chen; Xiaofeng Luo; Yun Lin; Lvying Shen; Mengxian Guo; Qiuru Chen; Min Xiao; Yongquan Chen; Xueqiong Wu; Yanling Zeng; Zhizhe Chen; Xudong Ma; Jianda Hu; Ting Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-01-26       Impact factor: 3.267

6.  Chlorhexidine Gluconate Bathing Reduces the Incidence of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Cell Transplantation.

Authors:  Vinay K Giri; Kristin G Kegerreis; Yi Ren; Lauren M Bohannon; Erica Lobaugh-Jin; Julia A Messina; Anita Matthews; Yvonne M Mowery; Elizabeth Sito; Martha Lassiter; Jennifer L Saullo; Sin-Ho Jung; Li Ma; Morris Greenberg; Tessa M Andermann; Marcel R M van den Brink; Jonathan U Peled; Antonio L C Gomes; Taewoong Choi; Cristina J Gasparetto; Mitchell E Horwitz; Gwynn D Long; Richard D Lopez; David A Rizzieri; Stefanie Sarantopoulos; Nelson J Chao; Deborah H Allen; Anthony D Sung
Journal:  Transplant Cell Ther       Date:  2021-01-07

7.  Home-Based Hematopoietic Cell Transplantation in the United States.

Authors:  Anthony D Sung; Vinay K Giri; Helen Tang; Krista Rowe Nichols; Meagan V Lew; Lauren Bohannon; Yi Ren; Sin-Ho Jung; Tara Dalton; Amy Bush; Jolien Van Opstal; Alexandra Artica; Julia Messina; Rebecca Shelby; Jennifer Frith; Martha Lassiter; Jill Burleson; Kari Leonard; Ashley S Potter; Taewoong Choi; Cristina J Gasparetto; Mitchell E Horwitz; Gwynn D Long; Richard D Lopez; Stefanie Sarantopoulos; Nelson J Chao
Journal:  Transplant Cell Ther       Date:  2022-01-20

Review 8.  Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis.

Authors:  C E Dandoy; M I Ardura; G A Papanicolaou; J J Auletta
Journal:  Bone Marrow Transplant       Date:  2017-03-27       Impact factor: 5.174

Review 9.  Possible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Shigeo Fuji; Markus Kapp; Hermann Einsele
Journal:  Front Oncol       Date:  2014-04-24       Impact factor: 6.244

Review 10.  STING and transplantation: can targeting this pathway improve outcomes?

Authors:  Cameron S Bader; Lei Jin; Robert B Levy
Journal:  Blood       Date:  2021-04-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.